Arzerra

In the US, Arzerra (ofatumumab systemic) is a member of the drug class CD20 monoclonal antibodies and is used to treat Chronic Lymphocytic Leukemia.

US matches:

• Arzerra

UK matches:

• Arzerra (SPC)
• Arzerra (citrate formulation) (SPC)

Ingredient matches for Arzerra

Ofatumumab

Ofatumumab is reported as an ingredient of Arzerra in the following countries:

• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.